COSM
Cosmos Health, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.33
+0.18%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.33
From 52W high−68.39%
Volume1.27M
Market cap$33.40M
P/E (TTM)—
P/S (TTM)0.5x
Div yield—
Key dataOct 19, 2026
Open
$0.33
From 52W high
−68.39%
Volume
1.27M
Market cap
$33.40M
ValuationView details →
P/E (Fwd)
2.6x
EV/EBITDA
−2.4x
P/E (TTM)
—
RSI (14)
50.5
MomentumView details →
1D Return
+0.18%
YTD Return
−32.60%
SummaryUpdated Jun 1, 2026
Cosmos Health Inc. (NASDAQ:COSM) is a vertically integrated pharmaceutical company founded in 2009 and headquartered in Chicago, Illinois. The company went public in July 2010 and operates as a specialty pharmaceutical manufacturer and distributor with a focus on branded and generic pharmaceuticals, nutraceuticals, and medical devices. Cosmos Health has established distribution operations across multiple countries, with key facilities in Greece and the United Kingdom, serving wholesale pharmaceutical distributors and independent retail pharmacies through both traditional distribution channels and e-commerce platforms.
Similar companies
Latest newsMore news →
Cosmos Health Inc. reported preliminary third-quarter 2026 revenue of $17.4 million, up 2% year over year, and nine-month revenue of $54.3 million, an increase of $8.7 million from the prior-year period; it also provided fiscal 2026 revenue guidance of at least $90 million.10d agoCosmos Health Inc. announced the launch of its Oliv18 nutraceutical product, a whole olive polyphenol formulation, with a staged rollout beginning with direct-to-consumer e-commerce and planned expansion into retail channels.56d ago